OLR1 and coronary artery disorder: Soluble LOX-1 (sLOX-1) is generated by alternate RNA splicing, proteolytic cleavage or ‘shedding’ of the LOX-1 extracellular domain: circulating sLOX-1 could be a sensitive biomarker of CVD, MI or CAD than cardiac troponins, traditional biomarkers of myocardial infarction [65,66].